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Although early myocardial reperfusion via primary percutaneous coronary intervention (PCI) allows the preservation
of left ventricular function and improves outcome, the acute restoration of blood flow may contribute to the
pathophysiology of infarction, a complex phenomenon called reperfusion injury. First described in animal models of
coronary obstruction, mechanical post-conditioning, a sequence of repetitive interruption of coronary blood flow
applied immediately after reopening of the occluded vessel, was able to reduce the infarct size. However, evidence of
its real benefit remains controversial. This review describes the mechanisms of post-conditioning action and the
different protocols employed focusing on its impact on primary PCI outcome.
 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
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STEMI ST-segment elevation myocardial infarction
Tn troponinIntroduction
For patients with ST-segment elevation myocar-dial infarction (STEMI), ‘‘time is myocar-
dium’’. Infarct size can be limited by early
myocardial reperfusion via primary percutaneous
coronary intervention (PCI), thus allowing the
preservation of left ventricular function and
improving clinical outcome [1,2]. However, the
acute restoration of blood flow may contribute to
the pathophysiology of infarction, a complex phe-
nomenon called reperfusion injury [3,4]. Indeed,
lethal reperfusion injury accounts for up to 50%
of the final size of a myocardial infarct [4]. In
2003, Zhao et al. [5] were the first to describe a
phenomenon known as ‘‘post-conditioning’’ in
which a sequence of repetitive interruption of cor-
onary blood flow was applied immediately after
reopening of the occluded vessel. This adjunct
treatment attenuated reperfusion injury, reduced
infarct size and preserved vascular endothelial
function comparable to ischemic preconditioning
in a canine model of coronary obstruction [5].
Since the first report in a human heart by Staat
et al. [6] in 2005, the interest in post-conditioning
has increased. Although various parameters have
been employed to assess its benefits, the real
impact of post-conditioning in PCI remains con-
troversial. The current review describes the mech-
anisms of post-conditioning action and the
different protocols employed, focusing on its real
impact on primary PCI outcome.Mechanisms of post-conditioning action
In experimental models, the effect of post-con-
ditioning on decreasing final infarct size is medi-
ated through different pathways [5–8]. The
molecular basis of post-conditioning action can
be subdivided into the following three headings:
triggers, mediators and end-effectors [7,8]
(Fig. 1). Several activators of the signaling cas-
cades (triggers) have been identified: adenosine,
opioids, bradykinin, erythropoietin, endogenous
nitric-oxide (eNO), acetylcholine, pro-inflamma-
tory cytokines (particularly TNF-a and IL-6) and
reactive oxygen species (ROS) [7]. The trigger
phase is characterized by extracellular receptor/ligand interactions with autacoid, endocrine or
paracrine signaling molecules [8]. The mediators
of post-conditioning action can be subdivided into
two pathways: the first is represented by reperfu-
sion injury salvage kinase pathway, which
includes phosphoinositide-3-kinases and extracel-
lular regulated kinase-mitogen activated protein
kinase, while the second consists of the reduction
of intracellular calcium overload [7,8]. The mito-
chondrial permeability transition pore (mPTP)
and mitochondrial potassium ATP (mKATP)
channel [7] are currently considered as the most
important end-effectors. The opening of mPTP,
which is a voltage-dependent pore localized in
the inner mitochondrial membrane, has been
reported to occur within the first minutes of reper-
fusion. Such a phenomenon allows the transfer of
small molecules into the matrix by osmosis, which
is responsible for the swelling and rupturing of
outer mitochondrial membrane with subsequent
accumulation of calcium and other oxidants, even-
tually leading to alkalization of the intracellular
matrix, and thus to apoptosis [7,8]. In the rabbit
heart model, Argaud et al. [9] demonstrated that
the magnitude of the protective effect of post-con-
ditioning was similar to that obtained with
NIM811, which specifically inhibited mPTP open-
ing at the time of reperfusion. TRO40303 also
inhibits mPTP opening, and has been shown to
reduce infarct size in animal models of myocardial
infarction [10,11]. However, in the MITOCARE
study randomizing patients with STEMI requiring
primary PCI to TRO40303 (n = 83) or placebo
(n = 80) prior to balloon inflation, no significant
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Figure 1. Molecular basis of post-conditioning action. The mechanisms of action of post-conditioning can be subdivided into three headings:
triggers, mediators, and end-effectors. Several triggers have been recognized such as adenosine, opioids, bradykinin, erythropoietin, endogenous
nitric-oxide, acetylcholine, pro-inflammatory cytokines and ROS. The mediators of post-conditioning action can be subdivided into two
pathways: reperfusion injury salvage kinase pathway (PI3K, ERK-MAPK, PK G, PK C) and reduction of intracellular calcium overload. The
mitochondria is the key target of post-conditioning action in order to avoid apoptosis due to ischemia/reperfusion injury, and the end-effectors are
mPTP and mKATP. On the other hand, post-conditioning may also have a passive effect on improving endothelial dysfunction and decreasing
oxidant release, hypercontracture, cytokine levels, inflammation and apoptosis. Abbreviations: Ca = calcium; ERK-MAPK = extracellular
regulated kinase-mitogen activated protein kinase; eNO = endogenous nitric oxide; mKATP = mitochondrial potassium ATP; mPTP = mito-
chondrial permeability transition pore; PI3K = phosphoinositide-3-kinases; PK = protein kinase; ROS = reactive oxygen species.
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regarding infarct size assessed by necrosis
biomarkers and cardiac magnetic resonance imag-
ing (MRI) [12].
On the other hand, the use of glibenclamide and
5-OH decanoate, which are inhibitors of mKATP
channel, has been shown to reverse the protective
effects of post-conditioning [13]. It has also been
reported that intermittent targeting of the mKATPchannel in the early minutes of reperfusion trig-
gers post-conditioning protection through reactive
oxygen species generation [14].
Otherwise, post conditioning may also have
a passive impact on endothelial dysfunction,
oxidant release, hypercontracture, cytokine levels,
inflammation and apoptosis [7,8].
The majority of cellular signaling elements
involved in such a process might be affected by
Table 1. Protocols employed in different trials on post-conditioning in PCI.
Study Year Protocol of POC N POC/controls
Staat et al. [6] 2005 60 s  4 14/16
Ma et al. [34] 2006 30 s  3 47/47
Yang et al. [26] 2007 30 s  3 23/18
Thibault et al. [25] 2008 60 s  4 17/21
Sorensson et al. [27] 2010 60 s  4 38/38
Freixa et al. [28] 2012 60 s  4 39/40
Tarantini et al. [29] 2012 60 s  4 39/39
Zhao et al. [38] 2012 60 s  4 32/30
Hahn et al. [20] 2013 60 s  4 350/350
Dwyer et al. [41] 2013 30 s  4 50/52
Limalanathan et al. [23] 2014 60 s  4 136/136
Abbreviations: PCI = percutaneous coronary intervention and POC = post-conditioning.
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these conditions are associated with fundamental
molecular alterations, potentially explaining the
variability of responses to post-conditioning
between individuals [3].Mechanical post-conditioning protocols and
modalities
Accumulating evidence has suggested that sev-
eral technical issues may improve cardioprotec-
tion by post-conditioning, such as the balloon
position, the conditioning delay to first inflation,
and even the stenting technique. Thuny et al.
[15] suggested that the post-conditioning protocol
should be performed upstream of the site of the
culprit lesion in order to reduce microembolisms.
On the other hand, the delay to first inflation
has been recognized as an important determinant
of reduction in infarct size [16]. In fact, delay pro-
longation from 10 to 30 to 60 s [17,18] or 10 min [19]
has been shown to result in cardioprotection
failure in animal models.
In currently available trials, the post-condition-
ing protocols consisted of two to four cycles of
ischemia and reperfusion (produced by infla-
tions/deflations of angioplasty balloon) after direct
stenting [20–22]. Taking into account an average of
three cycles plus one balloon inflation for direct
stenting, the cut-off of four inflations would mimic
post-conditioning in a real-life practice. After PCI
of the presumed culprit lesion, the stent balloon is
commonly used to perform alternating inflations
and deflations. In the majority of studies, post-
conditioning was performed by four 30–60-s cycles
of low pressure balloon inflations (4–6 atm) at the
site of previous occlusion, each separated by 30–
60 s of reflow [20–23]. Table 1 summarizes the
various post-conditioning protocols employed in
different studies.Post-conditioning effects
Post-conditioning and injury biomarkers
Serum creatine-kinase (CK) release was the
most widely used study endpoint, and peak CK
values strongly correlate with infarct size and pre-
dict cardiac outcomes in STEMI patients treated
with primary PCI [24].
Yetgin et al. [21] found a lower CK peak in post-
conditioning group compared with controls, corre-
sponding to 21% reduction of enzymatic infarct
size. This finding was similar to those reported
by previous randomized studies, in which post-
conditioning resulted in CK release reduction
ranging from 27% to 40% [6,15,25,26]. However,
Hahn et al. [20] failed to demonstrate any advan-
tage of post-conditioning in terms of reperfusion
markers as assessed by complete ST-segment res-
olution (P70%), 30 min post-PCI and post-proce-
dural TIMI flow or myocardial blush grade in a
large randomized trial involving 700 STEMI
patients.
Other results from recent studies assessed with
troponin I (TnI) or TnT [27–30], were also contro-
versial with earlier observations. When TnT or
TnI were used as endpoints, there was no signifi-
cant difference between post-conditioning group
and controls (p = 0.74) [30]. In a multi-center ran-
domized controlled study, Roubille et al. [31]
failed to show any significant decrease in CK
and TnI release, even after adjustment for the size
of the area at risk. More recently, Limalanathan
et al. [23] showed no significant difference in
TnT peak between controls and post-conditioning
group (p = 0.63).
On the other hand, some factors may have an
influence on the impact of post-conditioning on
injury markers. According to Yetgin et al. [21],
the decrease in CK peak was more pronounced
in women, patients without diabetes or hypercho-
lesterolemia, patients presenting within 3–6 h or
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a meta-analysis of 13 studies, Wang et al. [30]
found that myocardial injury biomarkers were sig-
nificantly reduced in cases of non-use of Gp IIb/
IIIa inhibitors. A possible explanation is that Gp
IIb/IIIa inhibitors and post-conditioning proce-
dure may act via similar pathways, thus achieving
balance on protection, particularly against no-
reflow phenomenon.Post-conditioning and no-reflow
Despite the continuous improvement in PCI
equipment and techniques, 60–70% of patients
with optimal angiographic reperfusion still dis-
play microvascular obstruction (the so-called no-
reflow phenomenon) detected by cardiac MRI
studies after reperfusion [32]. After prolonged
ischemia reperfusion, endothelium destruction
or swelling, vasospasm, plugging of leukocytes
or red blood cells and micro-thrombi may lead
to the microcirculation perfusion deficit. Myocar-
dial edema and hemorrhage may contribute
by extrinsic compression causing microvascular
obstruction. Using contrast-enhanced cardiac-
MRI within 3 days after reperfusion, Mewton
et al. [32] showed that post-conditioning was asso-
ciated with smaller, early and late microvascular
obstruction size (p = 0.01). Furthermore, such a
significant reduction was persistent after adjust-
ment for thrombus aspiration [32].
Dong and colleagues [33] assessed the impact of
post-conditioning on various reflow determinants.
Compared with controls, patients who underwent
post-conditioning showed better rates of ST-seg-
ment resolution (93.8% versus 73.3%, p = 0.029),
final TIMI grade-3 flow (81.3% versus 56.7%,
p = 0.036), and final myocardial blush grade 3
(23% versus 14%, p = 0.043).
Although the number of patients in these two
studies was relatively limited (50 and 62 respec-
tively), post-conditioning could improve myocar-
dial reperfusion in patients with STEMI patients
undergoing PCI by reducing no-reflow [32,33].
In order to evaluate the impact of post-condi-
tioning on coronary blood flow velocity, Ma et al.
[34] reported that patients with post-conditioning
had much faster corrected TIMI frame count
8 weeks after the primary PCI. Moreover, the peak
of malondialdehyde, an oxidative agent which
is actively implicated in coronary endothelial
cytotoxicity, was significantly lower after post-
conditioning compared with controls [34]. This
latter finding revealed the probable impact of
post-conditioning in improving cardiac vascular
endothelial function after myocardial infarction.Conversely, Hahn et al. [20] did not find signifi-
cant differences neither in 30 min ST-segment res-
olution (p = 0.79) nor in blush flow grade 30 days
later (p = 0.20).Post-conditioning and left ventricular function
Comparing 32 patients who underwent post-
conditioning to 30 controls treated by PCI for
acute myocardial infarction, Dong et al. [33] found
a better echocardiographic left ventricular ejection
fraction (LVEF) in a post-conditioned group
(55.1 ± 9.8% versus 42.9 ± 10.7%, p = 0.042), 7 days
after the procedure. Two meta-analyses [30,35]
reported the same findings with an improvement
of LVEF after post-conditioning of 4.2% and
3.55%, respectively. However, it is usually
recognized that only an increase of LVEF > 5% is
considered significant improvement in patients
with abnormal LVEF.
In canine models, Zhao et al. [5] reported that
ischemic post-conditioning did not improve myo-
cardial segment contractile function in the first 3 h
after reperfusion. Moreover, Vinten-Johansen
et al. [36] and Couvreur et al. [37] revealed that
ischemic post-conditioning was not able to protect
against myocardial stunning in dogs and rabbits.
Such findings may explain the fact that at short-
term follow up, Zhao et al. [38] found similar con-
tractile function in post-conditioned and control
groups. However, at 6-month follow-up, the
authors demonstrated an increased LVEF and
reduced wall motion score index in the post-
conditioned group compared with controls [38].
Thibault et al. [25] also observed a persistent
infarct size reduction at 6 months assessed by
myocardial scintigraphy, and an improved recov-
ery of myocardial contractile function at 1-year
control echocardiography. Conversely, Wang
et al. [30] found LVEF reduction during medium
and long-term follow-up, which could be due to
left ventricular remodeling.
Furthermore, studies using cardiac MRI have
emerged revealing modest reductions [15,39–41],
no impact [30,22], and perhaps even potential
increase in infarct size without improvement
[28,29]. By studying myocardial salvage after
3 months as judged by delayed enhancement car-
diac MRI, Lønborg et al. [41] found a 19% relative
reduction of infarct size in the post-conditioning
group (51 ± 16% of total area at risk versus
63 ± 17%, p < 0.01), corresponding to a 31%
increase in salvage ratio. Conversely, Dwyer
et al. [22] showed that post-conditioning neither
significantly increases myocardial salvage
(p = 0.08) nor reduces infarct size (p = 0.18)
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undergoing primary PCI. The same finding was
reported by Roubille et al. [31] Moreover, Freixa
et al. [28] found that post-conditioning was associ-
ated with lower myocardial salvage (4.1 ± 7.2 ver-
sus 9.1 ± 5.8% in controls; p = 0.004) and lower
myocardial salvage index (18.9 ± 27.4 versus
30.9 ± 20.5% in controls; p = 0.038) with no signifi-
cant differences in infarct size; and LVEF was
found among the groups at 1 week and 6 months.
More recently, in the POSTEMI trial, 272 patients
were randomized to post-conditioning group
(n = 136) and control group (n = 136); primary end-
point was infarct size measured by cardiac MRI
[23]. After 4 months, no difference was observed
between control group and post-conditioning
group in percentage of left ventricular mass mea-
sured by cardiac MRI (14.4% versus 13.5%, respec-
tively; p = 0.18) and LVEF after 4 months (55%
versus 56.5%, respectively; p = 0.19) [23].Post-conditioning and clinical outcome
Data regarding mid-term clinical follow-up are
limited. In a cohort of 225 patients, Deftereos
et al. [42] showed a lower 30-day rate of death or
re-hospitalization for any cause in post-condi-
tioned group compared with the control group
(12.4% versus 22.3%; p = 0.05). Conversely, in a
multicenter randomized trial including 700
patients, Hahn et al. [20] assessed clinical out-
comes at 1 month from procedures. No differences
were observed between post-conditioned patients
and controls regarding death (3.7% versus 2.7%;
p = 0.53) and major adverse cardiac events
(MACE) (4.3% versus 3.7%; p = 0.70). At 4 months,
Limalanathan et al. [23] reported no significant
difference between post-conditioned patients
and controls regarding re-hospitalization for acute
coronary syndromes or heart failure.
In another report, Tarantini et al. [29] showed
even higher rates of major adverse events at 6-
month follow-up in post-conditioned group com-
pared with control group (16.7% versus 2.6%;
p = 0.08).
In a meta-analysis of 15 randomized trials
including 1545 patients with a mean follow-up of
4.7 months, Khalili et al. [43] did not note any
impact of mechanical post-conditioning on mor-
tality (OR = 1.52; 95% CI 0.77–2.99; p = 0.23), recur-
rent myocardial infarction (OR = 3.04; 95% CI
0.74–12.54; p = 0.12), stent thrombosis (OR = 1.24,
95% CI 0.51–3.04; p = 0.83), or the composite
MACE outcome (OR = 1.53; 95% CI 0.89–2.63;
p = 0.13).Pharmacological post-conditioning
alternative
As an alternative to intra-coronary balloon infla-
tions, several pharmacological agents designed to
prevent lethal myocardial reperfusion injury by
targeting its components have been evaluated in
STEMI patients undergoing primary PCI. The
most investigated of these pharmacological
adjuncts were natriuretic peptide [44], cyclospor-
ine A [45], and adenosine [46]. Kitakaze et al. [44]
randomly assigned 277 patients to receive intrave-
nous atrial natriuretic peptide for 3 days and 292
patients to receive the same dose of placebo.
Patients with acute myocardial infarction and
who were given atrial natriuretic peptide had
lower infarct size of 14.7% (95% CI 3.0–24.9%),
and better LVEF at 6–12 months (ratio 1.05, 95%
CI 1.01–1.10, p = 0.024) [44]. Piot et al. [45] ran-
domly assigned 58 patients receiving either an
intravenous bolus of cyclosporine A or normal sal-
ine (control group) immediately before undergo-
ing primary PCI. The release of CK was
significantly reduced in the cyclosporine group
as compared with the control group (p = 0.04),
while the release of troponin I was not signifi-
cantly reduced (p = 0.15) [45]. On the fifth day,
the absolute mass of the area of hyper-enhance-
ment on MRI was significantly reduced in the
cyclosporine group as compared with the control
group, with a median of 37 g (interquartile range,
21–51) versus 46 g (interquartile range, 20–65;
p = 0.04). No adverse effects of cyclosporine
administration were detected [45]. More recently,
in placebo-controlled, randomized multicenter
trial including 240 STEMI patients, Nicolli et al.
[46] showed that the use of adenosine results not
only in significant improvement of microvascular
obstruction assessed by ST-segment resolution
but also in MACE occurrence at 30 days. Although
these are promising results, further studies are
required to confirm the efficacy of these therapeu-
tic agents and to determine whether they can
improve clinical outcomes, especially if combined
with intra-coronary balloon inflations.Remote ischemic conditioning alternative
Remote ischemic conditioning is based on the
fact that transient non-injurious ischemia of one
organ or tissue can protect a distant organ or tis-
sue from ischemic injury. Gho et al. [47] reported
that brief ischemia of the kidney or small intestine
was able to protect the myocardium against pro-
longed ischemia. Birnbaum et al. [48] demon-
strated that rabbit hindlimb ischemia protected
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et al. [49] moved the remote ischemic stimulus in
time, from before ischemia to later during the per-
iod of organ ischemia, and showed that renal
ischemia was cardioprotective.
To understand the mechanisms involved, three
theories have been advanced: (1) humoral factors
acting via the systemic circulation, particularly
eNO, ROS, adenosine, kininogens and opioids;
(2) neurogenic transmission with involvement of
muscle afferents and the autonomic nervous sys-
tem; and (3) effects on immune cells with reduc-
tion of neutrophil activation and adherence to
endothelium, and inflammatory gene expression
[50]. The final common pathway of protection in
the target organ involves activation of the reperfu-
sion injury salvage kinases or survival-activating
factor enhancement pathways that ultimately
converge on the mitochondria to open mKATP
channels, thereby preventing the opening of the
mPTP [7,8].
In a meta-analysis of 23 randomized clinical
trials of remote conditioning, most involving
patients undergoing cardiac surgery, limb condi-
tioning did not reduce mortality or major adverse
cardiovascular events compared with no condi-
tioning but did reduce the incidence of myocardial
infarction and troponin release [51]. Bøtker and
colleagues [52] reported the use of blood pressure
cuff inflation/deflation for four cycles of 5-min
occlusion in patients with STEMI before primary
PCI. The intervention group (n = 73) had higher
mean and median salvage indices at 30 days, esti-
mated by gated single photon emission computed
tomography, than the control group (n = 69). The
benefit was greatest in the subset of patients with
coronary vessel occlusion on admission angiogra-
phy. More recently, Crimi et al. [53] showed that in
patients with anterior STEMI, remote ischemic
conditioning of the lower limb at the time of pri-
mary PCI reduced enzymatic infarct size and
was also associated with ST-segment resolution
and improvement of T2-weighted edema volume
in cardiac MRI.Conclusion
Although the majority of the studies demon-
strate that post-conditioning might reduce injury
biomarkers, the other benefits of post-condition-
ing remain controversial, and data on long-term
outcomes are limited. Several confounders such
as co-morbidities, co-medication and the differ-
ence in post-conditioning protocols might be
responsible for the huge disparity observedbetween the various studies. Moreover, the lim-
ited number of randomized trials, including large
cohorts, and the significant variations encoun-
tered in clinical events when the STEMI model is
employed as a post conditioning model make it
difficult to confirm the impact of post-condition-
ing. Further studies are therefore needed to better
identify the best protocol to adopt, which patient
might gain more benefit from such a procedure,
and the overall possible benefits of associating
post-conditioning with pharmacological and
remote ischemic conditioning.References
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